The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
The Pathogenesis of Rheumatoid Arthritis
Abstract
The increased understanding of the immune mechanisms of rheumatoid arthritis has led to the development of a considerable number of new therapeutic agents that alter the natural history of the disease and reduce mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rheumatoid arthritis is a chronic autoimmune disease characterized by synovial inflammation that can result in damage to articular cartilage and bone.205”
From The oral microbiome: Role of key organisms and complex networks in oral health and disease (2021) · cites this paper as [205]
In the citing paper
“Development of rheumatoid arthritis occurs largely through a loss of tolerance for proteins that have undergone citrullination (ie, posttranslational modification of a positively charged arginine into a neutral citrulline group).205”
From The oral microbiome: Role of key organisms and complex networks in oral health and disease (2021) · cites this paper as [205]
Citations
Cites
1 retracted
Schuerwegh, A. J., Ioan‐Facsinay, A., Dorjée, A. L., Roos, J. A. D. M. D., Bajema, I. M., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913054107 · Cited by 94
RetractedGenome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.138461 · Cited by 4,959
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,653
Gregersen, P. K., Silver, J., & WINCHESTER, R. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301102 · Cited by 2,633
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. A. (2007) · Nature reviews. Immunology · doi:10.1038/nri2094 · Cited by 2,576
Self-citationRantapää‐Dahlqvist, S., Jong, B. A. W. D., Berglin, E. H., Hallmans, G., Wadell, G., Stenlund, H. C., Sundin, U., & VENROOIJ, W. J. V. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11223 · Cited by 1,946
Klareskog, L., Stolt, P., Lundberg, K., Källberg, H., Bengtsson, C., Grünewald, J., Rönnelid, J., Harris, H. E., Ulfgren, A., Rantapää‐Dahlqvist, S., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21575 · Cited by 1,516
Research works printed but not linked: 5
- Scher JU, 2010, Arthritis Rheum, 62, 1390
- Szekanecz Z, 2009, Front Biosci (Elite Ed), 1, 44
- Aupperle KR, 1998, Am J Pathol, 152, 1091
- Gravallese EM, 1998, Am J Pathol, 152, 943
- Jacobsson LT, 2005, J Rheumatol, 32, 1213
Cited by
Sorted by citations
Items 401–500 of 1,011
García, S., Hartkamp, L. M., Fernandez, B. M., van Es, I. E., Lin, H., Wong, J., Long, L., Zanghi, J. A., Rankin, A. L., Masteller, E. L., et al. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0973-6 · Cited by 114
You, S., Koh, J. H., Leng, L., Kim, W., & Bucala, R. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40406 · Cited by 114
Autophagy and Rheumatoid Arthritis: Current Knowledges and Future Perspectives
Vomero, M., Barbati, C., Colasanti, T., Perricone, C., Novelli, L., Ceccarelli, F., Spinelli, F. R., Franco, M. D., Conti, F., Valesini, G., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01577 · Cited by 116
“Several immune cells are involved: T and B cells, macrophages, synovial fibroblasts, chondrocytes, and osteoclasts, which lead to the release of different inflammatory mediators, sustaining the chronic inflammatory response of the disease (34).”
BackgroundPharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response
Scher, J. U., Nayak, R. R., Úbeda, C., Turnbaugh, P. J., & Abramson, S. B. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0395-3 · Cited by 116
You, S., Yoo, S., Choi, S., Kim, J., Park, S.-J., Ji, J. D., Kim, T., Kim, K., Cho, C., Hwang, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311239111 · Cited by 116
Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways
Liu, C., Jiang, J., Gao, L., Wang, X., Hu, X., Wu, M., Wu, J. H., Xu, T., Shi, Q., & Zhang, X. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0859-z · Cited by 113
Neuroimmune Communication in Health and Disease
Reardon, C., Murray, K. M., & Lomax, A. E. (2018) · Physiological Reviews · doi:10.1152/physrev.00035.2017 · Cited by 119
Barcode‐Enabled Sequencing of Plasmablast Antibody Repertoires in Rheumatoid Arthritis
Tan, Y., Kongpachith, S., Blum, L. K., Ju, C., Lahey, L. J., Lu, D., Cai, X., Wagner, C. A., Lindström, T. M., Sokolove, J. B., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38754 · Cited by 110
The effect of curcumin and its nanoformulation on adjuvant-induced arthritis in rats
Cai, H., Zheng, Z., Sun, Y., Liu, Z., Zhang, M., & Li, C. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s90147 · Cited by 111
Mechanisms involved in normal and pathological osteoclastogenesis
Park‐Min, K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2817-9 · Cited by 126
Wu, C., Yang, H., & Lai, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114015 · Cited by 112
“5%–1% of the population worldwide, and can conceivably lead to joint destruction and disability [1].”
BackgroundOral Microbiota: A Major Player in the Diagnosis of Systemic Diseases
Thomas, C., Minty, M., Vinel, A., Canceill, T., Loubières, P., Burcelin, R., Kaddech, M., Blasco‐Baqué, V., & Laurencin‐Dalicieux, S. (2021) · Diagnostics · doi:10.3390/diagnostics11081376 · Cited by 122
Interleukin-2 and regulatory T cells in rheumatic diseases
Kolios, A. G. A., Tsokos, G. C., & Klatzmann, D. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00707-x · Cited by 116
Glycine increased ferroptosis via SAM-mediated GPX4 promoter methylation in rheumatoid arthritis
Ling, H., Li, M., Yang, C., Sun, S., Zhang, W., Zhao, L., Xu, N., Zhang, J., Shen, Y., Zhang, X., et al. (2022) · Rheumatology · doi:10.1093/rheumatology/keac069 · Cited by 111
Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation
Zundler, S., Günther, C., Kremer, A. E., Zaiss, M. M., Rothhammer, V., & Neurath, M. F. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00663-1 · Cited by 112
T-cell exhaustion in immune-mediated inflammatory diseases: New implications for immunotherapy
Gao, Z., Feng, Y., Xu, J., & Liang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.977394 · Cited by 118
“T-cells are the main effector cells (54, 55).”
BackgroundCytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis
Moon, J., Younis, S., Ramadoss, N. S., Iyer, R., Sheth, K., Sharpe, O., Rao, N. L., Bécart, S., Carman, J., James, E. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35264-8 · Cited by 113
The role of the synovial fibroblast in rheumatoid arthritis pathogenesis
Turner, J. D., & Filer, A. D. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000148 · Cited by 115
Causes and consequences of endoplasmic reticulum stress in rheumatic disease
Navid, F., & Colbert, R. A. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.192 · Cited by 113
Araki, Y., & Mimura, T. (2016) · Journal of Immunology Research · doi:10.1155/2016/6290682 · Cited by 116
Ricard, L., Jachiet, V., Malard, F., Ye, Y., Stocker, N., Rivière, S., Senet, P., Monfort, J. ‐., Fain, O., Mohty, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214382 · Cited by 112
β-Sitosterol modulates macrophage polarization and attenuates rheumatoid inflammation in mice
Liu, R., Hao, D., Xu, W., Li, J., Li, X., Shen, D., Sheng, K., Zhao, L., Xu, W., Gao, Z.-E., et al. (2019) · Pharmaceutical Biology · doi:10.1080/13880209.2019.1577461 · Cited by 110
“The development of RA involves multiple steps, leading to the complex pathogenesis (Mcinnes and Schett 2011).”
BackgroundAutotaxin and chronic inflammatory diseases
Magkrioti, C., Galaris, A., Kanellopoulou, P., Stylianaki, E.-A., Kaffe, E., & Aidinis, V. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102327 · Cited by 113
Targeting ADAM10 in Cancer and Autoimmunity
Smith, T. M., Tharakan, A., & Martin, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00499 · Cited by 116
“An early histological hallmark of RA pathogenesis is synovial angiogenesis, which permits leukocyte infiltration and progression to synovitis (93).”
BackgroundInfluentialMetabolomics in rheumatoid arthritis: Advances and review
Xu, L., Chang, C., Jiang, P., Wei, K., Zhang, R., Jin, Y., Zhao, J., Xu, L., Shi, Y., Guo, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.961708 · Cited by 110
“The development of RA is associated with susceptibility genes, epigenetic modification, and the environment (1).”
BackgroundKellner, H. L. (2013) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x13485328 · Cited by 113
Collins, F. L., Irwin, R., Bierhalter, H., Schepper, J. D., Britton, R. A., Parameswaran, N., & McCabe, L. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153180 · Cited by 112
Neuron-immune mechanisms contribute to pain in early stages of arthritis
Nieto, F. R., Clark, A. K., Grist, J., Hathway, G. J., Chapman, V., & Malcangio, M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0556-0 · Cited by 111
Mechanistic biomarkers for clinical decision making in rheumatic diseases
Robinson, W. H., Lindstrom, T. M., Cheung, R. K., & Sokolove, J. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.14 · Cited by 109
Sohn, D. H., Rhodes, C., Onuma, K., Zhao, X., Sharpe, O., Gazitt, T., Shiao, R., Fert‐Bober, J., Cheng, D., Lahey, L. J., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39283 · Cited by 107
Martin, D. A., Churchill, M. A., Flores-Suárez, L. F., Cardiel, M. H., Wallace, D. J., Martin, R. W., Phillips, K., Kaine, J., Dong, H., Salinger, D. H., et al. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4347 · Cited by 109
Aleyd, E., Al, M., Tuk, C. W., van der Laken, C. J., & van Egmond, M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502353 · Cited by 108
Li, G.-M., Zhao, J., Li, B., Zhang, X., Ma, J., Ma, X., & Liu, J. L. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.10.013 · Cited by 113
Najm, A., Masson, F., Preuss, P., Georges, S., Ory, B., Quillard, T., Sood, S., Goodyear, C. S., Veale, D. J., Fearon, U., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41441 · Cited by 108
“Inflammatory cytokines including tumor necrosis factor (TNF), interleukin-1 (IL-1), IL-17, and IL-6 are part of the inflammatory milieu in RA (2).”
BackgroundLee, C., Huang, K., Shaw, J., Chen, J., Kuo, W., Shen, G., Grumezescu, A. M., Holban, A. M., Wang, Y.-T., Wang, J., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.575704 · Cited by 109
Kondoh, Y., Makino, S., Ogura, T., Suda, T., Tomioka, H., Amano, H., Anraku, M., Enomoto, N., Fujii, T., Fujisawa, T., et al. (2021) · Respiratory Investigation · doi:10.1016/j.resinv.2021.04.011 · Cited by 110
Luo, Y., Tong, Y., Wu, L., Niu, H., Li, Y., Su, L. C., Wu, Y., Bözec, A., Zaiss, M. M., Qing, P., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42616 · Cited by 108
The Role of Protein Arginine Methyltransferases in Inflammatory Responses
Kim, J. H., Yoo, B. C., Yang, W. S., Kim, E., Hong, S., & Cho, J. Y. (2016) · Mediators of Inflammation · doi:10.1155/2016/4028353 · Cited by 107
B cell checkpoints in autoimmune rheumatic diseases
Rubin, S. J. S., Bloom, M. S., & Robinson, W. H. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0211-0 · Cited by 109
Park, S. Y., Lee, S. W., Lee, S. Y., Hong, K. W., Bae, S. S., Kim, K., & Kim, C. D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01135 · Cited by 112
ER Stress: A Therapeutic Target in Rheumatoid Arthritis?
Rahmati, M., Moosavi, M. A., & McDermott, M. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.03.010 · Cited by 103
Ames-Sibin, A. P., Barizão, C. L., Ghizoni, C. V. D. C., Silva-Comar, F. M. D. S., de Sá‐Nakanishi, A. B., Bracht, L., Bersani‐Amado, C. A., Natali, M. R. M., Bracht, A., & Comar, J. F. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27369 · Cited by 108
“The pathophysiology of arthritis involves an intense cytokine‐mediated hyperplasia of the synovial membrane and overproduction of reactive oxygen species (ROS), which act as mediators of tissue injury.(10) In addition to inflammation, oxidative stress is increased in the joints and systemically.”
BackgroundNK Cells in Autoimmune Diseases: Protective or Pathogenic?
Liu, M., Liang, S., & Zhang, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624687 · Cited by 106
“, DCs, macrophages, mast cells, and NK cells) have also been implicated in RA pathogenesis (98, 102, 103).”
BackgroundJohansson, L., Sherina, N., Kharlamova, N., Potempa, B. A., Larsson, B., Israelsson, L., Potempa, J., Rantapää‐Dahlqvist, S., & Lundberg, K. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1100-4 · Cited by 105
Ansboro, S., Roelofs, A. J., & Bari, C. D. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000370 · Cited by 105
Tsukamoto, M., Seta, N., Yoshimoto, K., Suzuki, K., Yamaoka, K., & Takeuchi, T. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1216-6 · Cited by 108
Bioactive silicon nitride: A new therapeutic material for osteoarthropathy
Pezzotti, G., Marin, E., Adachi, T., Rondinella, A., Boschetto, F., Zhu, W., Sugano, N., Bock, R. M., McEntire, B. J., & Bal, B. S. (2017) · Scientific Reports · doi:10.1038/srep44848 · Cited by 104
Periodontal Health and Oral Microbiota in Patients with Rheumatoid Arthritis
Eriksson, K., Fei, G., Lundmark, A., Benchimol, D., Lee, L., Hu, Y. O. O., Kats, A., Saevarsdottir, S., Catrina, A., Klinge, B., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050630 · Cited by 101
“Inflammatory mediators play a central role in the pathogenesis of chronic inflammatory diseases such as periodontitis and RA, promoting autoimmunity and maintaining a chronic inflammation that collectively contribute to tissue and bone destruction [5,51].”
BackgroundAssociation between environmental air pollution and rheumatoid arthritis flares
Adami, G., Viapiana, O., Rossini, M., Orsolini, G., Bertoldo, E., Giollo, A., Gatti, D., & Fassio, A. (2021) · Lara D. Veeken · doi:10.1093/rheumatology/keab049 · Cited by 104
Specialized pro-resolving mediators as modulators of immune responses
Julliard, W. A., Myo, Y. P. A., Perelas, A., Jackson, P., Thatcher, T. H., & Sime, P. J. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101605 · Cited by 112
Immune mechanisms of depression in rheumatoid arthritis
Brock, J., Basu, N., Schlachetzki, J. C. M., Schett, G. A., McInnes, I. B., & Cavanagh, J. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-01037-w · Cited by 108
Self-citationSanayama, Y., Ikeda, K., Saito, Y., Kagami, S., Yamagata, M., Furuta, S., Kashiwakuma, D., Iwamoto, I., Umibe, T., Nawata, Y., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38400 · Cited by 105
Modulation of TNF-Induced Macrophage Polarization by Synovial Fibroblasts
Donlin, L. T., Jayatilleke, A., Γιαννοπούλου, Ε., Kalliolias, G. D., & Ivashkiv, L. B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400486 · Cited by 108
Duroux-Richard, I., Pers, Y., Fabre, S., Ammari, M., Baeten, D., Cartron, G., Touitou, I., Jørgensen, C., & Apparailly, F. (2014) · Mediators of Inflammation · doi:10.1155/2014/342524 · Cited by 103
Yang, W., Zhang, W.-H., Ying, H., Xu, Y., Zhang, J., Min, Q., Huang, B., Jin, L., Chen, J., & Wang, X. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.07.007 · Cited by 103
“Rheumatoid arthritis (RA) is an autoimmune disease with chronic inflammation of the synovial joints that marked by variable cycles of remissions and relapses and eventually induced severe disability [1,2].”
BackgroundMediterranean Diet and Incidence of Rheumatoid Arthritis in Women
Hu, Y., Costenbader, K. H., Gao, X., Hu, F. B., Karlson, E. W., & Lü, B. (2014) · Arthritis Care & Research · doi:10.1002/acr.22481 · Cited by 107
Defibrotide: Properties and clinical use of an old/new drug
Pescador, R., Capuzzi, L., Mantovani, M., Fulgenzi, A., & Ferrero, M. E. (2013) · Vascular Pharmacology · doi:10.1016/j.vph.2013.05.001 · Cited by 101
Romão, V. C., Canhão, H. M., & Fonseca, J. E. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-17 · Cited by 102
Penatti, A. E., Facciotti, F., Matteis, R. D., Larghi, P., Paroni, M., Murgo, A., Lucia, O. D., Pagani, M., Pierannunzii, L., Truzzi, M. C., et al. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1305-1 · Cited by 102
Shadmanfar, S., Labibzadeh, N., Emadedin, M., Jaroughi, N., Azimian, V., Mardpour, S., Kakroodi, F. A., Bolurieh, T., Hosseini, S.-E., Chehrazi, M., et al. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2017.12.009 · Cited by 102
Pathogenic Citrulline‐Multispecific B Cell Receptor Clades in Rheumatoid Arthritis
Titcombe, P. J., Wigerblad, G., Sippl, N., Zhang, N., Shmagel, A., Sahlström, P., Zhang, Y., Barsness, L. O., Ghodke‐Puranik, Y., Baharpoor, A., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40590 · Cited by 102
“The successful treatment of RA with anti-CD20 (B cell–depleting) rituximab also suggests critical B cell involvement in the disease (2,3).”
BackgroundZhang, Y., Wang, G., Wang, T., Cao, W., Zhang, L., & Chen, X. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14196 · Cited by 102
“(Nrf2) and heme oxygenase-1 (HO-1), (2) reducing expression of Kelch-like ECH–related protein 1 (Keap1),”
BackgroundEmerging roles of IL-34 in health and disease
Lelios, I., Cansever, D., Utz, S. G., Mildenberger, W., Stifter, S. A., & Greter, M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190290 · Cited by 105
Accelerated immunosenescence in rheumatoid arthritis: impact on clinical progression
Bauer, M. E. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00178-w · Cited by 107
“The presence of the shared epitope in HLA favours the binding of self-proteins that have undergone post-translational modification in a process referred to as citrullination – a physiological process that can be intensified by the presence of a risk allele in the PTPN22 gene, which is also a genetic risk factor for RA…”
BackgroundDai, Y., Wang, W., Yu, Y., & Hu, S. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05320-z · Cited by 102
He, Y., Liu, C., Zeng, Z., Wei-lin, Y., Lin, J., & Ou, Q. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3871-7 · Cited by 101
Engdahl, C., Bondt, A., Steffen, U., Raufer, J., Pfeifle, R., Camponeschi, A., Wuhrer, M., Seeling, M., Mårtensson, I., Nimmerjahn, F., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1586-z · Cited by 101
Self-citationPotential Implications of Long Noncoding RNAs in Autoimmune Diseases
Hur, K., Kim, S.-H., & Kim, J. (2019) · Immune Network · doi:10.4110/in.2019.19.e4 · Cited by 99
Hirose, S., Lin, Q., Ohtsuji, M., Nishimura, H., & Verbeek, J. S. (2019) · International Immunology · doi:10.1093/intimm/dxz036 · Cited by 106
“Monocytes/macrophages accumulate in arthritic synovial-joint tissues and produce large amounts of inflammatory cytokines (9).”
BackgroundNeutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritis
O’Neil, L. J., Barrera‐Vargas, A., Sandoval-Heglund, D., Merayo‐Chalico, J., Aguirre-Aguilar, E., Aponte, A. M., Ruiz‐Perdomo, Y., Guček, M., El-Gabalawy, H. S., Fox, D. A., et al. (2020) · Science Advances · doi:10.1126/sciadv.abd2688 · Cited by 101
“RA synovial joints are characterized by hyperplasia of the synovial lining, which is composed of invasive FLS and an infiltration of immune cells such as neutrophils, T cells, macrophages, B cells, and plasma cells (25, 26).”
Cheng, L., Wang, Y., Wu, R., Ding, T., Xue, H., Gao, C., Li, X., & Wang, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.709178 · Cited by 104
“The sublining layer likewise expands, with inflammatory cell infiltrates, consisting of macrophages, plasma cells, T cells along with B cells (22).”
BackgroundCalprotectin as a Biomarker for Rheumatoid Arthritis: A Systematic Review
Abildtrup, M., Kingsley, G. H., & Scott, D. L. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.140628 · Cited by 101
A Randomized Phase II b Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis
Weinblatt, M. E., McInnes, I. B., Kremer, J. M., Miranda, P., Vencovský, J., Guo, X., White, W. I., Ryan, P. C., Godwood, A., Albulescu, M., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40323 · Cited by 101
Self-citationNiu, Q., Huang, Z., Wu, X., Jin, Y., An, Y., Li, Y., Xu, H., Yang, B., & Wang, L. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1690-0 · Cited by 100
Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells
Lorenzetti, R., Janowska, I., Smulski, C. R., Frede, N., Henneberger, N., Walter, L. I., Schleyer, M.-T., Hüppe, J. M., Staniek, J., Salzer, U., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.04.016 · Cited by 101
Lee, J., Mannaa, M., Kim, Y., Kim, J., Kim, G.-T., & Seo, Y. (2019) · Genes · doi:10.3390/genes10100748 · Cited by 103
“So far, RA has been the main focus for studying the microbiome’s role in autoimmunity [6].”
BackgroundShi, Y., Xie, F., Rao, P., Qian, H., Chen, R., Hu, C., Li, D., Mu, D., Zhang, L., Lv, P., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.054 · Cited by 101
Melatonin effects on bone: Implications for use as a therapy for managing bone loss
Munmun, F., & Witt‐Enderby, P. A. (2021) · Journal of Pineal Research · doi:10.1111/jpi.12749 · Cited by 101
Yoon, B. R., Yoo, S.-J., Choi, Y. H., Chung, Y., Kim, J., Yoo, I. S., Kang, S. W., & Lee, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109775 · Cited by 106
Luo, Q., Sun, Y., Liu, W., Cheng, Q., Jin, B., Tao, F., Gu, Y., Wu, X., Shen, Y., & Xu, Q. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300832 · Cited by 99
How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
Steffen, U., Schett, G. A., & Bözec, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01483 · Cited by 103
Self-citationBa, X., Huang, Y., Shen, P., Huang, Y., Wang, H., Han, L., Lin, W., Yan, H., Xu, L. J., Qin, K., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.696802 · Cited by 109
Vagus nerve stimulation: A new bioelectronics approach to treat rheumatoid arthritis?
Koopman, F. A., Schuurman, P. R., Vervoordeldonk, M. J., & Tak, P. P. (2014) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2014.10.015 · Cited by 99
Rosas, E. C., Corrêa, L. B., Pádua, T. A., Costa, T. E. M. M., Mazzei, J. L., Heringer, A. P., Bizarro, C. A., Kaplan, M. A. C., Figueiredo, M. R., & Henriques, M. D. G. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.10.014 · Cited by 98
Inflammatory Cell Migration in Rheumatoid Arthritis: A Comprehensive Review
Nevius, E., Gomes, A. C., & Pereira, J. P. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8520-9 · Cited by 100
Hambardzumyan, K., Bolce, R. J., Saevarsdóttir, S., Cruickshank, S., Sasso, E. H., Chernoff, D., Forslind, K., Petersson, I. F., Geborek, P., & van Vollenhoven, R. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204986 · Cited by 98
Rheumatoid arthritis risk in periodontitis patients: A systematic review and meta-analysis
Qiao, Y., Wang, Z., Li, Y., Han, Y., Zhou, Y., & Cao, X. (2020) · Joint Bone Spine · doi:10.1016/j.jbspin.2020.04.024 · Cited by 98
Lin, Y., Yi, O., Hu, M., Hu, S., Su, Z., Liao, J., Wang, W., Wang, S., Liu, L., Liu, B., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.016 · Cited by 104
Pan, T. S., Cheng, T.-F., Jia, Y.-R., Li, P., & Li, F. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.04.020 · Cited by 98
EGCG Attenuates Autoimmune Arthritis by Inhibition of STAT3 and HIF-1α with Th17/Treg Control
Yang, E., Lee, J. J., Lee, S.-Y., Kim, E., Moon, Y., Jung, Y. O., Park, S., & Cho, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086062 · Cited by 97
Liao, K. P., Kurreeman, F. A. S., Li, G., Duclos, G. E., Murphy, S. N., Guzman, R. J., Cai, T., Gupta, N., Gainer, V. S., Schur, P. H., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37801 · Cited by 99
Su, X., Huang, Q., Chen, J., Wang, M., Pan, H., Wang, R., Zhou, H., Zhou, Z., Liu, J., Yang, F., et al. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.031 · Cited by 98
Postmenopausal osteoporosis in rheumatoid arthritis: The estrogen deficiency-immune mechanisms link
Sapir‐Koren, R., & Livshits, G. (2017) · Bone · doi:10.1016/j.bone.2017.06.020 · Cited by 99
NLRP3 inflammasome regulates Th17 differentiation in rheumatoid arthritis
Zhao, C., Gu, Y., Zeng, X., & Wang, J. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.09.007 · Cited by 103
Chemokines and chemokine receptors as promising targets in rheumatoid arthritis
Murayama, M. A., Shimizu, J., Miyabe, C., Yudo, K., & Miyabe, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1100869 · Cited by 97
“This results in synovial inflammation, hyperplasia and swelling, cartilage and bone destruction and deformity, and systemic features, such as cardiovascular, pulmonary, and skeletal disorders (70).”
BackgroundScleritis: Immunopathogenesis and molecular basis for therapy
Wakefield, D., Girolamo, N. D., THURAU, S. R., Wildner, G., & McCluskey, P. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.02.004 · Cited by 98
Zingiber officinale: A Potential Plant against Rheumatoid Arthritis
Al‐Nahain, A., Jahan, R., & Rahmatullah, M. (2014) · Arthritis · doi:10.1155/2014/159089 · Cited by 97
Zhao, N., Li, C.-C., Di, B., & Xu, L.-L. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102515 · Cited by 103
Matrix Metalloproteinases in Non-Neoplastic Disorders
Tokito, A., & Jougasaki, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071178 · Cited by 98
Impact of Yoga on Inflammatory Biomarkers: A Systematic Review
Djalilova, D., Schulz, P., Berger, A., Case, A., Kupzyk, K., & Ross, A. (2018) · Biological Research for Nursing · doi:10.1177/1099800418820162 · Cited by 77
Metadata
- Authors
- McInnes, I. B., & Schett, G.
- Affiliations
- University of Glasgow (GB)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-12-08
- Volume
- 365
- Issue
- 23
- Pages
- 2205-2219
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2110826367
- Cited by
- 5,514
- References
- 100
- Citations by year
- 2026: 313 · 2025: 415 · 2024: 439 · 2023: 443 · 2022: 469 · 2021: 493 · 2020: 465 · 2019: 409 · 2018: 399 · 2017: 394 · 2016: 379 · 2015: 300 · 2014: 276 · 2013: 204 · 2012: 111
- FWCI
- 27.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- rheumatoid arthritis, pathogenesis, immune mechanisms, disease-modifying antirheumatic drugs, mortality reduction
- MeSH terms
- Arthritis, Rheumatoid, Humans, Antirheumatic Agents, Gene-Environment Interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review